1.87
price up icon0.54%   0.01
after-market Dopo l'orario di chiusura: 1.96 0.09 +4.81%
loading
Precedente Chiudi:
$1.86
Aprire:
$1.88
Volume 24 ore:
240.30K
Relative Volume:
0.42
Capitalizzazione di mercato:
$97.83M
Reddito:
$21.05M
Utile/perdita netta:
$-89.22M
Rapporto P/E:
-1.0447
EPS:
-1.79
Flusso di cassa netto:
$-64.50M
1 W Prestazione:
-1.06%
1M Prestazione:
+11.31%
6M Prestazione:
-25.79%
1 anno Prestazione:
-73.44%
Intervallo 1D:
Value
$1.8284
$1.90
Intervallo di 1 settimana:
Value
$1.75
$1.91
Portata 52W:
Value
$1.02
$7.44

Tscan Therapeutics Inc Stock (TCRX) Company Profile

Name
Nome
Tscan Therapeutics Inc
Name
Telefono
857-399-9500
Name
Indirizzo
880 WINTER STREET, WALTHAM
Name
Dipendente
201
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
TCRX's Discussions on Twitter

Confronta TCRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TCRX
Tscan Therapeutics Inc
1.87 104.69M 21.05M -89.22M -64.50M -1.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-16 Iniziato BTIG Research Buy
2024-05-13 Iniziato Needham Buy
2023-06-22 Iniziato Wedbush Outperform

Tscan Therapeutics Inc Borsa (TCRX) Ultime notizie

pulisher
Jul 24, 2025

Does TScan Therapeutics Inc. stock pay reliable dividendsDynamic capital growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How high can TScan Therapeutics Inc. stock price go in 2025Game-changing returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about TScan Therapeutics Inc. stockExponential return rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

TScan Therapeutics Inc. Stock Analysis and ForecastJaw-dropping returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is TScan Therapeutics Inc. a good long term investmentFree Capital Efficiency Planning - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives TScan Therapeutics Inc. stock priceTremendous return rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

One TScan Therapeutics Insider Raised Stake By 18% In Previous Year - Yahoo.co

Jul 19, 2025
pulisher
Jul 15, 2025

Why TScan Therapeutics Inc. stock attracts strong analyst attentionStrategic High Profit Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How TScan Therapeutics Inc. stock performs during market volatilityShort Term High Return Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes TScan Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

TScan Therapeutics (NASDAQ:TCRX) Rating Increased to Hold at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Great week for TScan Therapeutics, Inc. (NASDAQ:TCRX) institutional investors after losing 73% over the previous year - simplywall.st

Jul 11, 2025
pulisher
Jul 09, 2025

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

TScan Therapeutics (NASDAQ:TCRX) Stock Price Down 4% – Time to Sell? - Defense World

Jul 08, 2025
pulisher
Jul 02, 2025

TScan Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jul 02, 2025
pulisher
Jul 02, 2025

TScan Therapeutics elects directors and ratifies auditor at annual meeting - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

TScan Therapeutics, Inc.(NasdaqGM: TCRX) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80 - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Wall Street Zen Downgrades TScan Therapeutics (NASDAQ:TCRX) to Sell - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Has $456,000 Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Makes New $59,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Boosts Stock Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Makes New $40,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Jun 05, 2025
pulisher
May 30, 2025

BNP Paribas Financial Markets Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

May 30, 2025
pulisher
May 28, 2025

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Cancer Therapy Pioneer TScan Therapeutics Set for Major Presentation at Jefferies Healthcare Conference - Stock Titan

May 28, 2025
pulisher
May 26, 2025

TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

TScan Therapeutics’ SWOT analysis: biotech firm’s stock faces pivotal year - Investing.com

May 26, 2025
pulisher
May 26, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail

May 26, 2025

Tscan Therapeutics Inc Azioni (TCRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):